Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. reports recurring developments in outpatient diagnostic imaging, digital health, and radiology technology. The company operates owned and managed imaging centers that provide MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, nuclear medicine, and related procedures for physicians and patients across U.S. markets.
RadNet news commonly covers financial results, imaging-center procedure volumes, guidance updates, joint ventures, acquisitions, and customer or technology collaborations. Its Digital Health segment includes DeepHealth, which provides radiology information technology, AI-powered health informatics, clinical AI applications, patient engagement tools, operational AI, teleradiology services, and related products for the diagnostic imaging industry.
Summary not available.
Summary not available.
RadNet, Inc. (NASDAQ: RDNT) will host a conference call on May 9, 2023, at 7:30 a.m. PT (10:30 a.m. ET) to discuss its first quarter financial results. Investors can join the call by dialing 844-826-3035 (U.S.) or 412-317-5195 (international). Archived webcasts will be available online. RadNet is a leading provider of diagnostic imaging services in the U.S., operating 357 outpatient centers across several states including California, New York, and Florida. The company employs over 9,000 professionals and offers radiology information technology and AI solutions in addition to imaging services.
RadNet, a national leader in diagnostic imaging services, announced that Mark Stolper, Executive Vice President and CFO, will present at the Sidoti & Company Spring 2023 Conference on March 22, 2023, at 1:00 p.m. Eastern Time. The event will be accessible via live and archived webcasts on their website and the provided link. RadNet operates 357 outpatient imaging centers across several states, employing over 9,000 personnel. As a top provider of fixed-site diagnostic imaging services in the U.S., RadNet focuses on delivering high-quality, cost-effective solutions.
RadNet, a leader in diagnostic imaging services, announced that Mark Stolper, CFO, will present at the Barclays Global Healthcare Conference on March 16, 2023, at 9:30 a.m. ET (6:30 a.m. PT). The location is the Loews Miami Beach Hotel. Interested parties can access the presentation via live and archived webcasts on their website and through the provided URL. RadNet operates a vast network of 357 outpatient imaging centers in key states like California and New York, employing over 9,000 staff to provide top-quality, cost-effective services.
RadNet, a leading provider of diagnostic imaging services in the U.S., will have Mark Stolper, CFO, and Gregory Sorensen, CEO of DeepHealth, present at the Cowen & Company Healthcare Conference on March 7, 2023, at 9:50 a.m. Eastern Time. The presentation will highlight RadNet's advancements in imaging technology and artificial intelligence. Interested parties can access live and archived webcasts at https://wsw.com/webcast/cowen132/rdnt/2026416 and through the RadNet website under the News section. As of now, RadNet operates 357 imaging centers across several states with over 9,000 employees.
RadNet (NASDAQ: RDNT) reported a 15.2% increase in revenue for Q4 2022, reaching $383.9 million, compared to $333.1 million in Q4 2021. Excluding the AI segment, revenue from Imaging Centers grew 15.1%, totaling $382.5 million. Adjusted EBITDA rose 18.4% to $61.6 million. The company announced guidance for 2023, projecting revenue between $1.525 billion and $1.575 billion, with a growth rate of 7%-10%. RadNet is also expanding its AI-powered breast cancer detection services, predicting that losses from the AI segment will decrease significantly in 2023, potentially turning profitable in 2024.
RadNet, Inc. (NASDAQ: RDNT) will host a conference call on February 28, 2023, at 7:30 a.m. PT to discuss its fourth quarter 2022 financial results. Investors can join the call by dialing 877-407-0789 (U.S.) or 201-689-8562 (international). The event will also be available via webcasts, with an archived replay accessible through designated dial-ins. RadNet is a leading provider of diagnostic imaging services in the U.S., operating 349 imaging centers across various states. The company specializes in radiology IT and AI solutions, teleradiology services, and employs approximately 9,000 individuals.
RadNet, Inc. (NASDAQ: RDNT) has initiated its Enhanced Breast Cancer Detection (EBCD) service, designed to improve breast cancer screening accuracy in New York and New Jersey. This service incorporates the Saige-Dx™ AI technology, an advanced tool for analyzing mammograms, alongside personalized lifetime risk assessments and a dedicated support line. EBCD aims to empower patients by offering more informative mammograms and addressing their concerns regarding breast cancer risk. The service is supported by extensive AI training on over one million images, enhancing radiologists’ efficiency and accuracy. RadNet continues to lead in AI-driven radiology solutions.
On February 6, 2023, RadNet (NASDAQ: RDNT) announced the launch of its Enhanced Breast Cancer Detection (EBCD) service. This innovative service integrates advanced AI technologies, including Saige-Dx™, to provide patients with enhanced mammography accuracy and personalized lifetime risk assessments for breast cancer. The program aims to improve early detection through AI-driven analysis and includes a support line for patient inquiries. According to company executives, the EBCD service enhances the quality of breast cancer screenings, ultimately aiming to improve patient outcomes.